Literature DB >> 9370877

Measurement of synovial lining volume by magnetic resonance imaging of the knee in chronic synovitis.

G Clunie1, M A Hall-Craggs, M N Paley, A King, I D Wilkinson, P J Ell, J C Edwards.   

Abstract

OBJECTIVES: Current methods of monitoring chronic synovitis in a single joint rely on clinical examination derived indices, such as the detection of synovial thickening. This study aimed to develop a reproducible method for quantifying the volume of synovial lining in chronic synovitis using contrast enhanced magnetic resonance (MR) imaging.
METHODS: The knees of 18 patients with chronic synovitis were examined (34 studies). A 2D T1 weighted FLASH sequence was used to evaluate the temporal enhancement of synovial structures after intravenous contrast. Synovial lining volume was calculated from subtraction of pre and post-enhancement 3D T1 weighted MP RAGE images with thresholding and pixel counting. Eleven patients were examined before and after intra-articular glucocorticoid (mean interval 14 weeks) and MR data compared with changes in clinical examination derived indices of disease activity.
RESULTS: Synovial lining volume varied from 52-267 ml. The coefficient of variation in volume calculation was 3.5% for a single observer and was 3.8% for two observers. Synovial lining volume was quantified in all patients where synovial lining thickening could not be detected clinically. A decrease in synovial lining volume of > 40% was associated with an improvement in synovial lining thickening, detected clinically. Decreases in synovial lining volume were quantified by MR in two of three patients where changes in clinical examination derived indices were inconsistent.
CONCLUSIONS: A reproducible method of estimating the volume of synovial lining in patients with chronic synovitis has been developed. MR measurement of synovial lining volume may quantify changes in chronic synovitis that remain unidentified by clinical measures.

Entities:  

Mesh:

Year:  1997        PMID: 9370877      PMCID: PMC1752445          DOI: 10.1136/ard.56.9.526

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  26 in total

1.  MR imaging of the knee in acute rheumatoid arthritis: synovial uptake of gadolinium-DOTA.

Authors:  A G Björkengren; P Geborek; U Rydholm; S Holtås; H Petterson
Journal:  AJR Am J Roentgenol       Date:  1990-08       Impact factor: 3.959

2.  Osmotic flows across the blood-joint barrier.

Authors:  J R Levick; A D Knight
Journal:  Ann Rheum Dis       Date:  1987-07       Impact factor: 19.103

3.  Respiratory gases of synovial fluids. An approach to synovial tissue circulatory-metabolic imbalance in rheumatoid arthritis.

Authors:  K H Falchuk; E J Goetzl; J P Kulka
Journal:  Am J Med       Date:  1970-08       Impact factor: 4.965

4.  Articular indices of joint inflammation in rheumatoid arthritis. Correlation with the acute-phase response.

Authors:  P W Thompson; A J Silman; J R Kirwan; H L Currey
Journal:  Arthritis Rheum       Date:  1987-06

5.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

6.  Rheumatoid arthritis: MR imaging manifestations.

Authors:  J Beltran; J L Caudill; L A Herman; S M Kantor; P N Hudson; A M Noto; A S Baran
Journal:  Radiology       Date:  1987-10       Impact factor: 11.105

7.  Hypoxia and acidosis in chronic inflammatory arthritis; relation to vascular supply and dynamic effusion pressure.

Authors:  J R Levick
Journal:  J Rheumatol       Date:  1990-05       Impact factor: 4.666

8.  Rheumatoid arthritis: evaluation of hypervascular and fibrous pannus with dynamic MR imaging enhanced with Gd-DTPA.

Authors:  H König; J Sieper; K J Wolf
Journal:  Radiology       Date:  1990-08       Impact factor: 11.105

9.  The influence of blood pressure on trans-synovial flow in the rabbit.

Authors:  A D Knight; J R Levick
Journal:  J Physiol       Date:  1984-04       Impact factor: 5.182

10.  Synovial fluid acidosis correlates with radiological joint destruction in rheumatoid arthritis knee joints.

Authors:  P Geborek; T Saxne; H Pettersson; F A Wollheim
Journal:  J Rheumatol       Date:  1989-04       Impact factor: 4.666

View more
  5 in total

1.  Intra-articular methotrexate in the treatment of rheumatoid arthritis and psoriatic arthritis: a clinical and sonographic study.

Authors:  Annamaria Iagnocco; Angela Cerioni; Giulio Coari; Alejandra Ossandon; Raffaele Masciangelo; Guido Valesini
Journal:  Clin Rheumatol       Date:  2005-06-10       Impact factor: 2.980

2.  Importance of timing of post-contrast MRI in rheumatoid arthritis: what happens during the first 60 minutes after IV gadolinium-DTPA?

Authors:  M Østergaard; M Klarlund
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

3.  Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography.

Authors:  Steven T Proulx; Edmund Kwok; Zhigang You; M Owen Papuga; Christopher A Beck; David J Shealy; Christopher T Ritchlin; Hani A Awad; Brendan F Boyce; Lianping Xing; Edward M Schwarz
Journal:  Arthritis Rheum       Date:  2007-12

4.  MR evaluation of radiation synovectomy of the knee by means of intra-articular injection of holmium-166-chitosan complex in patients with rheumatoid arthritis: results at 4-month follow-up.

Authors:  Sang Hoon Lee; Jin Suck Suh; Ho Seok Kim; Jong Doo Lee; Jungsik Song; Soo Kon Lee
Journal:  Korean J Radiol       Date:  2003 Jul-Sep       Impact factor: 3.500

Review 5.  Detection of calcium phosphate crystals in the joint fluid of patients with osteoarthritis - analytical approaches and challenges.

Authors:  Alexander Yavorskyy; Aaron Hernandez-Santana; Geraldine McCarthy; Gillian McMahon
Journal:  Analyst       Date:  2008-02-01       Impact factor: 4.616

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.